At the company’s Stein facility, the contract development and manufacturing organization is building a second commercial aseptic antibody-drug conjugate filling line.
The expanded partnership adds Lilly’s injectable device to its production, creates 400 jobs, and increases U.S. capacity for diabetes and obesity medicines.
Join this webinar to discover how data orchestration and Digital Threads provide the trusted context needed to scale Industrial AI, accelerate Smart Manufacturing, and drive measurable operational results.
